IN8BIOINAB

13F holders, Q2 2025 (June 30)
11holders
$2.09avg. 13F price*

At the end of Q2 2025, 11 institutions reported holding IN8BIO Inc. (INAB) in their 13F filings. The largest holders were Franklin Resources Inc. ($397K), AIGH Capital Management LLC ($313K) and Alyeska Investment Group, L.P. ($172K).

Company
IN8BIO Inc.
CUSIP
45674E208
Latest filing quarter
Q2 2026

History

Number of 13F holders

0510152025 Q2 2025: 11Q2 2025Q3 2025: 18Q3 2025Q4 2025: 22Q4 2025Q1 2026: 19Q1 2026Q2 2026: 21Q2 2026

Total Exit/New Position Q2 2025

InstitutionsTotal Value
New Positions1$172K
Exits0$0

Ownership 11 holders

Franklin Resources Inc. 0.00% Reduce -16.7% 189,894 $397K
AIGH Capital Management LLC 0.15% Add +158.4% 149,895 $313K
Alyeska Investment Group, L.P. 0.00% Reduce -0.8% 82,484 $172K
Stonepine Capital Management, LLC 0.17% New 82,430 $172K
Vanguard Group Inc. 0.00% Reduce -16.7% 60,097 $126K
Geode Capital Management, LLC 0.00% Reduce -17.3% 18,820 $39K
Northwestern Mutual Wealth Management Co. 0.00% Add +835.8% 3,093 $6K
Tower Research Capital LLC (TRC) 0.00% Add +86.9% 1,517 $3K
UBS Group AG 0.00% Reduce -2.9% 479 $1K
BlackRock, Inc. 0.00% Reduce -96.4% 84 $176
Bank of America Corp. 0.00% Add +23.7% 24 $50

"% of holder's portfolio" is INAB's weight in each manager's 13F, not the share of IN8BIO Inc. the manager owns.